Cutting Edge Thoughts on Drug Regulation by Matt Zorn
Lawyer
Irreverent commentary on Cannabis industry business, law, and capital markets since 2018 (ask me about older posts!).
An independent journalism newsletter supported by the U.C. Berkeley Center for the Science of Psychedelics